Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of treatments for human disease. The company's four drug programs are: XERMELO? (telotristat ethyl), an orally-delivered small molecule drug for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy; sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for type 1 and type 2 diabetes; LX2761, an orally-delivered small molecule drug candidate, as a treatment for diabetes; as well as LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain.
  • TickerLXRX
  • ISINUS5288723027
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

Liana Moussatos ...
  • Shveta Dighe

Q1: XERMELO® Sales Slight Miss; Next in Q2: First Top-line Zynquista™/T2D Data

1 director bought

A director at Lexicon Pharmaceuticals Inc bought 182,838 shares at 12.510USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. ...

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ValuEngine Rating and Forecast Report for LXRX

ResearchPool Subscriptions

Get the most out of your insights

Get in touch